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Background: Tuberculous pleural effusion (TPE) is one of the most common forms of extrapulmonary tuberculosis.
Because most studies of TPE focused on the pleural space, little information regarding lung parenchyma is
available. We therefore aimed to investigate immune responses in the lung parenchyma of TPE patients without
pulmonary tuberculosis.
Methods: Patients with any evidence of pulmonary tuberculosis, either from radiologic or bacteriologic evaluation,
were excluded. Bronchoalveolar lavage fluid (BALF) was collected from 10 newly diagnosed, untreated, HIV-negative
TPE patients and 10 healthy controls. We analyzed T-lymphocyte subpopulations and measured 10 cytokines in
BALF. Cytokine levels in BALF were standardised using urea.
Results: The concentrations of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), vascular endothelial growth
factor (VEGF), and the CD4+/CD8+ ratio of T-lymphocytes were significantly higher in TPE patients without
pulmonary tuberculosis than in the controls. Of the cytokines measured in BALF, VEGF showed the highest
concentration. No difference was observed in T-helper type 2 cytokines between the 2 groups.
Conclusion: There were significant immune responses and increases in IFN-γ, TNF-α, and VEGF in the lung
parenchyma of TPE patients without pulmonary tuberculosis. This result suggests that TPE may induce a significant
immune response in lung parenchyma.
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Tuberculosis (TB) is responsible for more deaths world-
wide than any other curable infectious disease. The clin-
ical manifestations of TB are determined by host
immune factors in response to mycobacterium infection.
Tuberculous pleural effusion (TPE) is one of the most
common forms of extrapulmonary tuberculosis [1,2].
The pathophysiology of TPE has been characterized by
T-cell-mediated hypersensitivity reaction to mycobacter-
ium or antigens thereof, in the pleural space. This process
involves the accumulation of protein-enriched fluid and
the migration of immune cells that are generally* Correspondence: wichoi@dsmc.or.kr
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reproduction in any medium, provided the orlymphocytic, with a particular predominance of CD4+
T- cells [3]. T helper-type 1 (Th1) cytokine levels are
increased at pleural effusion in patients with TPE [4,5].
Strong Th1 activity is required for successful immunity
against Mycobacterium tuberculosis. Interferon-gamma
(IFN-γ), a Th1-type cytokine, is an important factor for
immune responses to TB infection.[6] Mutations or cer-
tain polymorphisms in IFN-γ receptors increase suscepti-
bility to M. tuberculosis infection, and in cases in which
IFN-γ cannot be produced or cannot exert its effects, TB
infection is more severe and often fatal [7,8]. Tumor ne-
crosis factor-alpha (TNF-α) has been shown to have anti-
mycobacterial activity and promotes granuloma
formation in TB patients [7,9]. TNF-αmay also be respon-
sible for the toxic syndrome and tissue necrosis accom-
panying TB infection [10]. Several studies have reported
that TPE is a Th1-dominant environment, and that Th1td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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pleural effusions in patients with TPE [4,11,12]. Vascular
endothelial growth factor (VEGF) is another cytokine
involved in the immune response to TB infection. VEGF
is a potent multifunctional cytokine that contributes to
angiogenesis and inflammation. TNF-α, VEGF, and IFN-γ
levels are increased at pleural effusions in patients with
TPE, suggesting a role for these cytokines in the immune
response to mycobacterium infection [12,13].
Most previous studies on TPE have focused on the
pleural space. Therefore, little information is available
on lung parenchyma in TPE patients without pulmonary
tuberculosis. TPE patients often have systemic symp-
toms such as fever. Therefore, we aimed to investigate
the lung parenchymal immune response in TPE patients
without pulmonary tuberculosis. We hypothesized those
TPE patients without pulmonary tuberculosis would
have pulmonary immunological changes. We investi-
gated the levels of various cytokines and the compos-
ition of cells in the bronchoalveolar lavage (BAL) fluids
in TPE patients without pulmonary tuberculosis.
Methods
Study subjects
Newly diagnosed untreated patients with TPE and
healthy controls were enrolled in this study, which was
approved by Keimyung University Dongsan Hospital In-
stitutional Review Board. All patients were seronegative
for HIV, and none was receiving corticosteroids or other
immunosuppressive drugs. None of the patients or con-
trols had ever smoked or had a previous history of tuber-
culosis. TPE was diagnosed by clinical manifestations,
chest radiographic findings, exudative pleural effusion
showing lymphocyte predominance, absence of cancer
cells, and adenosine deaminase (ADA) level (>40 IU/L)
[14,15]. We performed M. tuberculosis polymerase chain
reaction (MTB-PCR) analysis, acid-fast bacilli (AFB)
smear, and AFB culture using bronchoalveolar lavage
fluid (BALF), sputum, and pleural fluid in all study sub-
jects except control. We excluded any patients who
showed any evidence of pulmonary tuberculosis either
from radiologic or bacteriologic evaluation. As control
subjects, 9 men and 1 woman with a mean age of
45 ± 14 years volunteered to participate in the study. All
volunteers had normal chest radiographic findings, no
symptoms of disease, and were not taking any medica-
tion. Written informed consent was obtained from all
patients and the control group prior to bronchoscopy.
Bronchoalveolar lavage
Bronchoscopy was performed according to a standar-
dized protocol, and BALF was collected for microbiologic
and immunologic examination including mycobacterial
smear and culture, biochemical and cytological analysis,and MTB-PCR and cytokine assays. In brief, a flexible
bronchoscope was wedged in the right middle lobe or
lingula of the left upper lobe, at the same side of the
TPE while the patient was under intravenous sedation.
Sterile saline (30 mL) at room temperature was instilled
5 times, and the instilled fluid was aspirated using gentle
suction after each aliquot and collected into sterile poly-
propylene tubes. Any subject who could not tolerate the
entire procedure or whose returned fluid was <60% of
the total infused volume was excluded from further
study. The fresh BAL fluid samples were immediately
stored at 4°C, and samples were sent to the relevant
diagnostic laboratories. The pooled BAL fluid was cen-
trifuged at 800 g for 10 min. The supernatant fluid was
rapidly frozen and stored at −80°C prior to use. PCR
testing for M. tuberculosis complex was performed using
the AMPLICOR kits (Roche Diagnostics, Mannheim,
Germany) for respiratory specimen preparation, amplifi-
cation, and detection with the COBAS AMPLICOR
analyzer (Roche Diagnostics, Basel, Switzerland) according
to the manufacturer’s instructions. Differential counts
were performed on Wright-Giemsa-stained cytocentrifuge
preparations, which were made with a cytospin. The cell
pellets were resuspended in RPMI 1649 medium and used
for lymphocyte subset analysis by flow cytometry
(FACScan; Becton Dickinson, Mountain View, USA).
Bronchoscopy was performed on all patients before they
commenced antituberculous chemotherapy. In the con-
trol group, BALF collection was performed in the right
middle lobe bronchus.
Cytokine assay
Assays of cytokines in BALF were performed using a
Bio-Plex human cytokine 10-plex assay kit (Bio-Rad,
USA) according to the manufacturer’s instructions. Bio-
Plex cytokine assays are multiplex bead-based assays in-
volving diverse matrices that are designed to quantify
multiple cytokines. The 10-plex assay kit contains beads
conjugated to monoclonal antibodies specific for inter-
leukin (IL)-1-alpha (IL-1α); IL-1-beta (IL-1β); IL-2, -4,
-6, -8, and −10; TNF-α; INF-γ; and VEGF. The frozen
aliquots of BALF were thawed to room temperature
prior to each assay. Standard curves and the concentra-
tion of cytokines within samples were generated with
the Bio-Plex Manager Software (Bio-Rad, USA).
Standardization of cytokine concentrations in BAL fluid
(BALF) by using urea
The standardization of cytokine levels in the BALF is
based on the concept that aliquots of sterile normal sa-
line infused through the bronchoscope mix with epithe-
lial lining fluid (ELF). When the saline is recovered by
aspiration, the ELF and its components are recovered
along with it. BALF cytokine concentration was adjusted
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determined after correction of dilution factor as ratio of
serum urea/BAL urea [10,16].Statistical analysis
All values were expressed as means ± standard deviation.
Data were analysed by SPSS version 18 (SPSS Inc.,
USA). A χ2 test was used to compare frequencies. The
Wilcoxon signed-rank sum test was used for the com-
parison. Bonferroni correction was performed in the
multiple comparisons. Differences were considered sig-
nificant at P < 0.05.Results
Basic information and results of examinations
During the study period, 12 TPE patients were enrolled;
of these, 1 patient showed AFB culture-positive BAL, and
1 patient showed MTB-PCR-positive BAL. These 2
patients were subsequently excluded. We therefore ana-
lysed 6 female and 4 male TPE patients. In the pleural
fluid microbiologic study, 1 patient showed MTB-PCR-
positive, and another 1 patient showed AFB culture-
positive. The mean age of the TPE patients was
48± 21 years. Pleural effusions were unilateral in all
patients. Five patients (50%) had right-side pleural effu-
sions, and 5 (50%) had left-side pleural effusions.
In the TPE group, 5 patients (50%) yielded positive tu-
berculin skin tests (>10 mm) and 6 patients (60%) had
fever. All TPE patients finished the short course of tu-
berculosis treatment without treatment-failure or side
effects. Pleural thickening was observed 6 months after
finishing treatment in 1 patient. There was no significant
difference in mean age between the TPE and control
groups.Table 2 Cytokine levels in bronchoalveolar lavage fluid
TPE group Control group P value
IFN-γ 17.36±17.26 1.43±1.95 0.0045*
TNF-α 18.92±15.04 4.24±4.29 0.004*Differential cells recovered from BALF
The BALF differential cell counts in TPE patients
compared to the controls are presented in Table 1. The
ratio of CD4+/CD8+ T lymphocytes was significantlyTable 1 Bronchoalveolar lavage fluid differential cell
counts in the tuberculous pleural effusion (TPE) and
control groups
TPE group Control group P value
CD4/CD8+ ratio 2.8 ± 1.14 1.56 ± 0.82 0.002
Alveolar macrophage (%) 85.3 ± 14 91.3 ± 5.03 NS
Lymphocytes (%) 12 ± 10.6 7.45 ± 5.26 NS
Neutrophils (%) 2.55 ± 4.09 0.8 ± 0.71 NS
Eosinophils (%) 0.25 ± 0.35 0.5 ± 0.85 NS
Cell number (104/mL) 10 ± 12 12 ± 9 NS
Data represent mean ± SD; NS = not significant.
* Bonferroni correction p< 0.0083.increased in the BALF of TPE patients than in that of
the controls.
Levels of cytokines in BALF
The IFN-γ, TNF-α, and VEGF levels in BALF were sig-
nificantly higher in TPE patients than in the controls
(Table 2). The levels of all other cytokines, except IL-10,
measured were higher in the TPE group than in the
control group.
Discussion
In the present study, we found that BALF from TPE
patients without pulmonary tuberculosis contained
increased levels of IFN-γ, TNF-α, and VEGF. Moreover,
we found an increase in the CD4+/CD8+ ratio of T lym-
phocytes in BALF from the TPE patients.
We measured the TNF-α level in BALF of newly diag-
nosed, untreated TPE patients without pulmonary tuber-
culosis. The TNF-α level was nearly 5-fold higher in
TPE patients than in the controls. In previous studies,
TNF-α level has been found to be higher in BALF in
patients with pulmonary TB than that in healthy con-
trols [10,17]. Other studies demonstrated that TNF-α
level in BALF in smear-negative active pulmonary TB
patients were 4.4-fold higher than that in the controls
[18], and higher TNF-α mRNA expression levels in the
lungs of mice with latent tuberculosis infection (LTBI)
compared to the controls [19]. Thus, the increase in
TNF-α levels in BALF observed in the present study
could result from an inflammatory reaction in response
to tuberculosis infection.
VEGF is an angiogenesis and inflammatory mediator,
which has been associated with TB infection activity,
[13,20] and levels decline after successful TB treatmentIL-1α 16.37±23.44 4.74±3.83 0.069
IL-1β 22.45±31.76 2.78±3.62 0.035
IL-2 6.26±19.79 0.74±1.68 0.195
IL-4 34.16±46.72 8.17±11.23 0.052
IL-6 5.78±18.27 0.94±2.08 0.207
IL-8 132.73±280.57 8.68±11.45 0.089
IL-10 17.63±29.55 22.24±25.79 0.357
VEGF 115.28±99.21 3.709±5.349 0.001*
TPE = tuberculous pleural effusion; values represent mean ± SD; data after
standardization shown as picograms per millilitre of epithelial lining fluid (ELF)
(pg/mL ELF; IFN-γ= interferon gamma; TNF-α= tumor necrosis factor-alpha;
IL-1α= interleukin-1-alpha; IL-1β= interleukin 1-beta; IL-2 = interleukin-2;
IL-4 = interleukin-4; IL-6 = interleukin-6; IL-8 = interleukin-8; IL-10 = interleukin-10;
VEGF = vascular endothelial growth factor).
* Bonferroni correction p< 0.005.
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from patients with TPE without pulmonary tuberculosis
were 31-fold higher than that in the controls. In previ-
ous studies, VEGF was measured in serum or in pleural
effusion among TB patients [12,21]. VEGF levels in
serum were approximately 2–4 times higher in patients
with active pulmonary TB than in the controls [21,22],
and in pleural effusion, it was approximately 15–39
times higher in patients with TPE compared to transu-
dates secondary to congestive heart failure [12,13]. An-
other study demonstrated that VEGF levels were higher
in LTBI patients than in the controls, and VEGF meas-
urement was one of the markers used to discriminate
LTBI from the controls [23]. As for TNF-α, we suggest
that an increase in VEGF levels in BALF indicates an in-
flammatory reaction in response to tuberculosis infec-
tion. In our study, VEGF was present in the highest
concentration among the cytokines measured. VEGF
levels of BALF can be elevated in acute lung injury
[24,25] and sarcoidosis [26]. Although VEGF is not a
specific for tuberculosis, it could be a sensitive inflam-
matory marker.
IFN-γ is known to be a key cytokine in the host im-
mune response to tuberculosis infection. Humans with
IFN-γ receptor abnormalities and IFN-γ-deficient mice
have increased susceptibility to M. tuberculosis infection
[8,27]. Previous studies have reported high levels of
IFN-γ in pleural effusions in TPE patients [11,28] and in
BALF from patients with active pulmonary TB [29,30]
or smear-negative active pulmonary TB [18]. An in vitro
study has also found that the level of PPD-induced IFN-γ
secretion by peripheral blood mononuclear cells (PBMC)
from LTBI subjects was 20 times higher than the cut-off
IFN-γ level (1.0 ng/ml) [31]. Another study found that
IFN-γ mRNA expression levels in the lungs of latent TB
mice were 7-times higher than that in the control mice
[19]. In our study, we found that the levels of IFN-γ in
BALF from TPE patients without pulmonary tuberculosis
were 12-fold higher than that in the controls. We suggest
that an increase in IFN-γ level in BALF indicates an in-
flammatory reaction in response to tuberculosis infec-
tion, similar to the IFN-γ test for LTBI.
It has been reported that cytokines associated with a T
helper-2 (Th-2) response, IL-4, and IL-10 were higher
than those associated with a Th-1 response in advanced
TB patients; however, Th-2 responses were lower in early
stages of TB infection [7]. In vitro stimulation of PBMC
with M. tuberculosis antigens elicited Th-2 responses [7].
Cytokine mRNA expression levels in the lungs of mice
indicated that Th-2 responses in LTBI mice were lower
than Th-1 responses, and also IL-10 mRNA expression
levels were lower than those of the control mice [19].
The present study showed that there was no difference in
Th-2 responses, defined by IL-4 and IL-10 levels,between TPE patients and the controls. However, IL-10
was the only cytokine whose levels in TPE patients were
lower than those in the controls. We suggest that Th-2
responses might have a minor role in the inflammatory
reactions evident in the present study.
Increases in the CD4+/CD8+ ratio of T lymphocytes
in BALF from active pulmonary TB patients, as com-
pared to controls, have previously been reported [32,33].
Another study has demonstrated that the CD4+/CD8+
ratio was higher in susceptible TB mice [34]. In the
present study, we showed that the CD4+/CD8+ ratio of
T lymphocytes changes in patients without active TB
infection.
Diagnosis of TPE based on ADA levels in pleural effu-
sion may have a limitation. The positive predictive value
(PPV) of pleural fluid ADA measurement in patients
with TPE is depends on local prevalence of the disease
[35]. The prevalence of TPE among all studied pleural
effusions in our institution was about 23% between 2005
and 2010. This finding suggested that ADA has more
than 80% of PPV in patients with TPE in our institution.
In addition to high PPV value of ADA, all TPE patients
in the present study were cured with anti-tuberculosis
medication.
Another potential limitation of the present study is
sensitivity of detecting active pulmonary tuberculosis by
simple chest radiograph. High-resolution computed
tomographies of patients with pleural tuberculosis were
more sensitive than simple chest radiographs in detecting
pulmonary tuberculosis activity [36]. We did not perform
computed tomography of the study subjects. Although
the present cases were all negative of BAL fluid MTB-
PCR, AFB stain, and AFB culture, there could be a little
possibility of active tuberculosis in the different lung re-
gion other than BAL area.Conclusions
We demonstrated significantly high levels of TNF-α,
IFN-γ, and VEGF and an increased CD4+/CD8+ ratio of
T lymphocytes in BALF from TPE patients without ac-
tive pulmonary tuberculosis. IFN-γ, TNF-α, and VEGF
would be an immune response markers of adjacent tis-
sue in response to tuberculosis.Abbreviations
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